Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by IQVIA

< Previous 1 2 3 Next >
Spending on U.S. Medicines Rose 12% in 2021 Due to COVID-19 Vaccines and Therapies, Says IQVIA Institute for Human Data Science
From IQVIA
Via Business Wire
Tickers IQV
IQVIA Selected to Support EMA’s DARWIN EU® Coordination Centre Initiative
From IQVIA
Via Business Wire
Tickers IQV
IQVIA Launches OCE+ To Deliver Enhanced AI-Driven Customer Engagement
From IQVIA
Via Business Wire
Tickers IQV
IQVIA Named Top CRO in 2021 WCG CenterWatch Independent Survey
From IQVIA
Via Business Wire
Tickers IQV
IQVIA Releases 2021 Environmental, Social, and Governance (ESG) Report
From IQVIA
Via Business Wire
Tickers IQV
Pharma R&D Pipeline and New Product Launches Reach Record Levels in 2021 According to New IQVIA Institute for Human Data Science Report
From IQVIA
Via Business Wire
Tickers IQV
IQVIA to Announce Fourth-Quarter and Full-Year 2021 Results on February 15, 2022
From IQVIA
Via Business Wire
Tickers IQV
Sheila A. Stamps Joins IQVIA Board of Directors
From IQVIA
Via Business Wire
Tickers IQV
Leslie Wims Morris Joins IQVIA Board of Directors
From IQVIA
Via Business Wire
Tickers IQV
Global Medicine Spending to Reach $1.8 Trillion in 2026, Including Spending on COVID-19 Vaccines, According to Study by the IQVIA Institute for Human Data Science
From IQVIA
Via Business Wire
Tickers IQV
IQVIA Decentralized Trial Suite Launches Mobile Research Nursing and Phlebotomy Services Unit
From IQVIA
Via Business Wire
Tickers IQV
IQVIA Recognized as a Leader in BPO Solutions for Pharmaceutical Sales and Marketing
From IQVIA
Via Business Wire
Tickers IQV
IQVIA Launches New Grants/Funding Management Module for Its Orchestrated Customer Engagement Platform
From IQVIA
Via Business Wire
Tickers IQV
IQVIA Launches New Grants/Funding Management Module for Its Orchestrated Customer Engagement Platform
From IQVIA
Via Business Wire
Tickers IQV
IQVIA to Announce Third-Quarter 2021 Results on October 21, 2021
From IQVIA
Via Business Wire
Tickers IQV
IQVIA Announces Opening of New Q2 Solutions Innovation Laboratories in North Carolina, Creating New Jobs and Expanded Capabilities
From IQVIA
Via Business Wire
Tickers IQV
Polpharma Selects IQVIA's Orchestrated Customer Engagement Platform to Improve Salesforce Productivity
From IQVIA
Via Business Wire
Tickers IQV
IQVIA and NRx Pharmaceuticals Collaborate on Potential Medical Support for Novel COVID-19 Treatment
From IQVIA
Via Business Wire
Tickers IQV
IQVIA Collaborates with HealthCore to Advance Clinical Research Using Real-World Data
From IQVIA
Via Business Wire
Tickers IQV
IQVIA Launches New A.I.-Powered MI Contact Center For Life Sciences
From IQVIA
Via Business Wire
Tickers IQV
Consumer Health Apps and Digital Health Tools Proliferate, Improving Quality and Health Outcomes for Patients, Says New Report from IQVIA Institute
From IQVIA
Via Business Wire
Tickers IQV
IQVIA Launches the Clinical Data Analytics Suite (CDAS) to Enable Smarter, Faster Clinical Trials
From IQVIA
Via Business Wire
Tickers IQV
Q² Solutions Announces Significant Expansion of Laboratory Operations in Scotland, UK
From IQVIA
Via Business Wire
Tickers IQV
Q2 Solutions and Tasso Collaborate to Provide Unique Solutions for Patients to Accelerate Adoption of Decentralized Clinical Trials
From IQVIA
Via Business Wire
Tickers IQV
Global Oncology Innovation Continues Despite Pandemic; Global R&D Pipeline Reached 3,500 New Drugs in 2020, up 75% from 2015, Says New Report from the IQVIA Institute for Human Data Science
From IQVIA
Via Business Wire
Tickers IQV
IQVIA CFO, Ron Bruehlman, to Speak at the William Blair Growth Stock Conference on June 2, 2021
From IQVIA
Via Business Wire
Tickers IQV
Pharma R&D Activity Surges Even Without COVID-19, Says Report from the IQVIA Institute for Human Data Science
From IQVIA
Via Business Wire
Tickers IQV
U.S. District Court Issues Favorable Decision for IQVIA Against Veeva
From IQVIA
Via Business Wire
Tickers IQV
IQVIA’s Orchestrated Customer Engagement (OCE) Solution Chosen to Support the Commercial Launch of Novel ADHD Drug
From IQVIA
Via Business Wire
Tickers IQV
Global Medicine Spending to Reach $1.6 Trillion in 2025 Excluding Spending on COVID-19 Vaccines, According to IQVIA Institute for Human Data Science Study
From IQVIA
Via Business Wire
Tickers IQV
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.